Georgia General Assembly · Full text

HR 1295: Tardive Dyskinesia Awareness Week 2026; first full week in May; recognize

Introduced version, the latest LegiScan holds · Last action February 9, 2026 · Passed

The text as LegiScan holds it, read from the PDF the legislature publishes with its margin line numbers, running heads, and page footers removed. Line breaks are joined into paragraphs here; no word is changed.

Copy for LLM, View as markdown, and Send to AI use the Markdown version: this text, then the summaries under a heading that names them as ours. View raw is the text alone.

Back to the summary

House Resolution 1295

By: Representatives Cooper of the 45th, Fleming of the 114th, Paris of the 142nd, and Martinez of the 111th

A RESOLUTION

Recognizing the first full week in May as Tardive Dyskinesia Awareness Week 2026; and for other purposes.

WHEREAS, serious mental illnesses like bipolar disorder, major depressive disorder, and schizophrenia often require treatment with antipsychotic medications for effective management, and antipsychotic prescribing rates continue to rise; and

WHEREAS, while prolonged antipsychotic use may be essential for the treatment of certain conditions, it is associated with tardive dyskinesia (TD), a condition marked by uncontrollable, abnormal, and repetitive movements of the face, torso, limbs, or extremities; and

WHEREAS, people at higher risk of TD include those older than 55 years, Black individuals, women, individuals with mood or substance use disorders, intellectual disabilities, or central nervous system injuries, and those with high cumulative antipsychotic exposure; and

WHEREAS, approximately 60 percent of the estimated 800,000 adults in the United States living with TD remain undiagnosed; and even mild TD symptoms can be stigmatizing and impair physical, social, and emotional well-being, underscoring the urgency of early screening, detection, and intervention; and

WHEREAS, the American Psychiatric Association recommends routine TD screening in their clinical guidelines for antipsychotic treatment, and individuals treated with antipsychotics or experiencing abnormal movements should consult their healthcare providers to assess TD risk, receive TD screenings, and determine appropriate treatment together; and

WHEREAS, FDA-approved treatments for TD can provide options for symptom management and improved quality of life for many individuals living with TD.

NOW, THEREFORE, BE IT RESOLVED BY THE HOUSE OF REPRESENTATIVES that the members of this body recognize the first full week in May as Tardive Dyskinesia Awareness Week 2026, prioritizing TD awareness, education, and routine screenings to improve care for individuals prescribed antipsychotics supports the health and well-being of Georgia's citizens.

BE IT FURTHER RESOLVED that the Clerk of the House of Representatives is authorized and directed to make appropriate copies of this resolution available for distribution to the public and the press.